January 19, 2017: Eli Lilly has finally set a date for the layoff of about 486 sales representatives working with the company’s U.S. Bio-Medicines business. The company will hand out pink slips beginning March 31.
January 19, 2017: Abbas Hussain, global head of Glaxo’s pharmaceuticals, is leaving the company. He will be replaced by Luke Miels, formerly executive VP of Astra.
January 19, 2017: Mallinckrodt will pay $100M to settle federal complaints the company violated antitrust laws after acquiring the rights to a drug that “threatened its monopoly in the U.S. market for ACTH drugs.”
January 19, 2017: There is a notion that the skills needed for scientists in academia are dramatically different than those needed in industry.